The health secretary says he will balance the arguments for and against mass testing ahead of a final decision due in March.

The FDA has approved a novel diagnostic for prostate cancer that looks to improve upon the common screener for ...

A marathon runner has said a prostate cancer test would have saved him from his terminal diagnosis. Tony Collier, 68, who has ...

The FDA has granted premarket approval (PMA) to the IsoPSA test, a novel, blood-based in vitro diagnostic kit designed to ...

Prostate cancer incidence is predicted to double to 2·9 million cases by 2040. Men diagnosed with clinically significant ...

A large primary care analysis shows prostate cancer screening remains underused and inequitable, with notable gaps for African American and low-income high-risk patients despite multiple risk factors.

Canadian research suggests recommendations against screening for prostate cancer has led to a rise in the rates of stage 4 ...

Targeted prostate cancer screening is helping identify men with early cases of the disease, says a group of Norwich health practices.

Prostate cancer tests in the UK will only be offered to men with a specific cancer gene variant in a controversial decision ...

A groundbreaking trial for a prostate cancer treatment with fewer side effects has launched in the UK. Backed by the ...

The therapy - which involves a robotic-assisted, high-pressure water jet - is less invasive than traditional surgery.